Comparing Your Options

Gastric Balloon vs Weight-Loss Injections vs Surgery

Three very different tools. None is universally “best” — they suit different starting points, timelines and goals. Here is an honest comparison based on published clinical evidence.

Average total body weight loss reported in published studies

Gastric balloon
10–15%


Semaglutide
~15%


Tirzepatide
~20%


Bariatric surgery
20–30%

Population averages from published clinical trials and systematic reviews, not outcomes tracked at this practice. Higher weight loss does not automatically mean a better choice for you — reversibility, ongoing cost, side effects and how long the effect lasts all matter, and are compared in the table below.

Gastric Balloon GLP-1 Injections Bariatric Surgery
What it is A soft balloon placed in the stomach for 4–12 months Weekly injection (semaglutide, tirzepatide) that alters appetite signalling Permanent surgical change to the stomach
Typical weight loss ~10–15% of body weight ~15% (semaglutide) to ~20% (tirzepatide) in trials ~20–30%, the most durable
Duration Temporary — removed after 4, 6 or 12 months Ongoing — taken indefinitely to hold results Permanent
Typical BMI range 27–40 (or 50+ as a bridge) 27+ with a weight-related condition, or 30+ 35+ (or 30+ with complications)
Anaesthesia Light sedation — or none at all with the swallowable balloon None General anaesthesia
Reversible? Fully — nothing is altered Yes — simply stop, but weight usually returns No
Main drawback Regain is common after removal without habit change Most of the weight returns if stopped; ongoing monthly cost; nausea common early Irreversible, longer recovery, surgical risk

About GLP-1 injections (Ozempic, Wegovy, Mounjaro)

These medicines have changed obesity treatment, and it is fair to say they work. In large published trials, semaglutide produced around 15% average weight loss and tirzepatide around 20% over roughly 72 weeks. For many patients they are an excellent choice.

Where they do well

  • No procedure, no sedation, no endoscopy — a weekly injection at home
  • Strong average weight loss, often the highest of the non-surgical options
  • Additional benefits for blood sugar, blood pressure and cholesterol
  • Weight loss continues for as long as the medicine is continued

Where patients run into difficulty

  • Stopping usually means regaining. In published trials, patients regained roughly two-thirds of the lost weight within a year of stopping.
  • It is an ongoing cost, not a one-off. Treatment is indefinite, and in the UAE it is largely self-funded.
  • Side effects are common early on — nausea, vomiting and constipation lead a meaningful number of patients to stop.
  • Muscle as well as fat is lost. Around a quarter to a third of the weight lost is lean mass, which is why resistance exercise and protein intake matter throughout.
  • Not suitable for everyone — personal or family history of medullary thyroid cancer, MEN2, or pancreatitis needs careful review.

Where the balloon fits

The balloon is a defined, time-limited reset. It creates real portion restriction for 4 to 12 months while you rebuild eating habits — then it comes out and nothing is left behind. That appeals to patients who want a finite commitment rather than an open-ended prescription, or who cannot tolerate the injections.

Its honest weakness is the mirror image of the injections: without genuine habit change during the balloon period, weight tends to return after removal. That is why diet, activity and follow-up are part of the treatment, not optional extras.

They are not mutually exclusive

Increasingly these are used in sequence rather than as rivals. Published work suggests that using a balloon first and adding a GLP-1 medicine afterwards can produce better twelve-month results than either alone, because the medicine helps hold the loss the balloon achieved. Evidence here is still developing, and whether it suits you is a conversation for consultation.

Figures quoted are population averages from published clinical literature, not outcomes tracked at this practice. Individual results vary. GLP-1 medicines must be prescribed and monitored by a licensed physician; this page is general education, not a recommendation for any specific medicine.

Medical disclaimer. The information on this website is provided for general education and does not replace an in-person consultation, examination or diagnosis by a licensed physician. Gastric balloon treatment is not suitable for everyone and individual results vary according to starting weight, medical history and adherence to the accompanying diet and lifestyle programme. No clinical outcome is guaranteed. Persistent vomiting, severe abdominal pain, or blue-green discoloured urine while a balloon is in place must be assessed urgently — contact the clinic immediately or attend the nearest hospital emergency department.

Licensing. Dr Kerim Erdem Ulucay — DHA Unique ID 00153417 · Physician-Specialist-General Surgery, licensed by the Dubai Health Authority. Facility licences: Armada Medical Centre (JLT) — DHA licence 00153417-005; Swift Day Surgical Center (Jumeirah) — DHA licence 00153417-006. All are DHA-licensed facilities.

Pricing. Gastric balloon treatment is a self-funded (cash) procedure and is generally not covered by UAE health insurance. Pricing is set by the treating facility and confirmed in writing before any commitment.

WhatsApp